• HyperScribe T7 High Yield RNA Synthesis Kit Plus

  2026-08-26

  Generate high-yield RNA for mRNA rescue, antisense studies, RNAi, and labeled probe workflows with a scalable T7 transcription system. The kit combines pre-supplemented polymerase, RNase inhibitor, pyrophosphatase, and modified-nucleotide compatibility to simplify demanding in vitro RNA production.

• IWP-L6: A Strategic Probe of Wnt Metabolism

  2026-08-25

  IWP-L6 offers translational researchers a potent way to interrogate Wnt biology at the Porcn-dependent ligand maturation step. This thought-leadership analysis connects mechanistic pathway blockade with developmental assays, metabolic osteogenesis, experimental design, and the practical limits that shape cross-species interpretation.

• ACE2 Peptidase Activity and Angiotensin (1-7)

  2026-08-25

  The 2024 reference study systematically tested how angiotensin peptide length and terminal residues affect competition for ACE2 activity. Its results identify Angiotensin II and Angiotensin III as the strongest natural substrates in the assay while showing that Angiotensin (1-7), the ACE2-generated product, behaves differently from its precursor.

• Muscle-Derived BDNF in Early NMJ Assembly

  2026-08-24

  The reference study shows that muscle-generated BDNF is not merely a diffusible trophic factor: its trafficking, capture, proteolytic maturation, and localized release at podosome-like structures help initiate postsynaptic acetylcholine receptor assembly. By combining live-cell imaging, molecular perturbation, and skeletal muscle-specific knockout models, the work connects subcellular BDNF organization with early neuromuscular junction development.

• Linoleic Acid (C18:2): Practical Assay Guide

  2026-08-24

  Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a controlled lipid input for oxidative stress, membrane, epithelial migration, erythrocyte, and essential fatty acid deficiency studies. It is appropriate for freshly prepared organic-solvent workflows but should not be selected for aqueous-only assays or experiments requiring long-term solution storage.

• LAMP1 Switches CXCL10-CXCR3 Macrophage Polarization

  2026-08-23

  The 2024 International Immunopharmacology study identifies LAMP1 as a context-dependent regulator of CXCL10-CXCR3 signaling in macrophage polarization. Its combination of macrophage perturbation, LAMP1 knockdown, autophagy profiling, and a poly(I:C)-induced lung injury model shows why CXCR3 antagonism can produce different outcomes in inflammatory and non-inflammatory states.

• Angiotensin II Workflows for Vascular Research

  2026-08-22

  Build reproducible cell and animal models of receptor-driven inflammation, oxidative stress, hypertension, and vascular remodeling with Angiotensin II. This guide connects practical dosing and storage decisions to macrophage polarization assays, smooth-muscle phenotyping, and abdominal aortic aneurysm research.

• Sodium Nitroprusside in Sex-Specific Vascular Research

  2026-08-22

  Sodium Nitroprusside provides a controlled nitric oxide donor challenge for separating vascular smooth muscle responsiveness from angiotensin II, hormonal, and autonomic effects. This workflow connects conscious-mouse telemetry with ex vivo vessel and platelet assays to improve sex-stratified hypertension research.

• WSP-5 for Reliable H2S Live-Cell Imaging

  2026-08-21

  Learn how WSP-5 (SKU C3378) can strengthen live-cell imaging of hydrogen sulfide alongside viability, proliferation, and cytotoxicity assays. This scenario-based guide covers probe chemistry, cardiomyocyte compatibility, practical handling, data interpretation, and vendor-selection criteria.

• Carbapenemase Gene Transfer in CREC

  2026-08-20

  A 2025 BMC Microbiology study combined plasmid elimination, PCR, antimicrobial susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. The study found frequent blaNDM-1 carriage and a high observed transfer rate of carbapenemase-encoding genes, emphasizing the value of tracking both resistance phenotypes and genetic mobility in antimicrobial resistance research.

• CD28–ARS2–PKM Splicing in CD8+ T Cells

  2026-08-20

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose catabolism. Its findings connect nuclear RNA processing with interferon-γ production and antitumor immunity, while showing that this metabolic program is distinct from canonical CD28–PI3K signaling.

• Isoprenaline Hydrochloride in Heart–Brain Models

  2026-08-19

  Learn how Isoprenaline Hydrochloride, also known as isoproterenol, can connect β-adrenergic stimulation with cardiac, vascular, and neurobehavioral readouts. This practical guide covers preparation, assay design, reference-backed parameters, heart–brain workflows, and troubleshooting.

• Metoprolol BA2737: Reliable Cell Assay Design

  2026-08-19

  Learn how Metoprolol (SKU BA2737) can be integrated into cell viability, proliferation, and cytotoxicity workflows without confusing pharmacology with assay artefact. This scenario-based guide covers controls, preparation, interpretation, storage, and practical vendor selection.

• BFH772 (VEGFR2 inhibitor): Practical Guide

  2026-08-18

  BFH772 is a selective VEGFR2 kinase inhibitor for experiments that require controlled modulation of VEGFR2-mediated angiogenic signaling and compatibility with organic solvents. It is not appropriate for workflows requiring a water-soluble preparation, broad-spectrum kinase inhibition, or direct extrapolation from biochemical potency to cellular or clinical dosing.

• Angiotensin I: RAS Precursor for Research

  2026-08-18

  Angiotensin I is a defined decapeptide and the immediate substrate-derived precursor of angiotensin II in the classical renin-angiotensin system. A1006 supports controlled ACE-conversion experiments, cardiovascular disease mechanisms, and antihypertensive drug screening when peptide identity, handling, and assay controls are explicit.

544 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page